Q1 2025 Holdings
Filed 2025-05-15 | 65 holdings | $1.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Natera Inc(NTRA) | COM | 632307104 | $219.2M | 1,550,280 | 14.3% |
| Stryker Corporation(SYK) | COM | 863667101 | $111.1M | 298,567 | 7.3% |
| Invesco QQQ TR(QQQ)Put | UNIT SER 1 | 46090E103 | $82.1M | 175,000 | 5.4% |
| iShares TR(IWM)Put | RUSSELL 2000 ETF | 464287655 | $69.8M | 350,000 | 4.6% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $67.1M | 2,793,987 | 4.4% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $63.3M | 510,050 | 4.1% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $50.6M | 562,992 | 3.3% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $47.6M | 176,181 | 3.1% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $46.9M | 418,900 | 3.1% |
| Eli Lilly & Co(LLY) | COM | 532457108 | $43.6M | 52,800 | 2.8% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $43.0M | 2,622,192 | 2.8% |
| Soleno Therapeutics Inc(SLNO)Put | COM | 834203309 | $37.8M | 529,300 | 2.5% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $34.6M | 484,471 | 2.3% |
| Arrivent BioPharma Inc(AVBP) | COM | 04272N102 | $31.4M | 1,696,752 | 2.0% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $29.5M | 579,339 | 1.9% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $28.0M | 2,275,223 | 1.8% |
| Dexcom Inc(DXCM) | COM | 252131107 | $27.0M | 395,975 | 1.8% |
| BridgeBio Pharma Inc(BBIO) | COM | 10806X102 | $25.4M | 734,227 | 1.7% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $24.2M | 2,479,939 | 1.6% |
| Rhythm Pharmaceuticals(RYTM) | COM | 76243J105 | $23.7M | 446,839 | 1.5% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $23.2M | 304,254 | 1.5% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $23.1M | 261,039 | 1.5% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $22.7M | 371,497 | 1.5% |
| Incyte Corp(INCY) | COM | 45337C102 | $21.7M | 357,800 | 1.4% |
| AnaptysBio Inc(ANAB) | COM | 032724106 | $21.6M | 1,160,033 | 1.4% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $20.9M | 327,618 | 1.4% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $20.6M | 510,020 | 1.3% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $20.4M | 175,317 | 1.3% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $20.0M | 1,995,594 | 1.3% |
| Supernus Pharmaceuticals Inc(SUPN) | COM | 868459108 | $17.1M | 520,678 | 1.1% |
| Savara Inc(SVRA) | COM | 805111101 | $15.2M | 5,481,666 | 1.0% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $13.1M | 2,182,121 | 0.9% |
| Roivant Sciences Ltd(ROIV) | SHS | G76279101 | $12.9M | 1,279,510 | 0.8% |
| Danaher Corporation(DHR) | COM | 235851102 | $12.0M | 58,606 | 0.8% |
| Penumbra Inc(PEN) | COM | 70975L107 | $11.5M | 42,936 | 0.7% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $11.2M | 379,931 | 0.7% |
| Inhibrx Biosciences Inc(INBX) | COM | 45720N103 | $9.8M | 697,916 | 0.6% |
| Y-mAbs Therapeutics Inc(YMABUSD) | COM | 984241109 | $9.7M | 2,194,278 | 0.6% |
| Aerovate Therapeutics Inc | COM | 008064107 | $9.4M | 3,758,686 | 0.6% |
| Pharvaris N V(PHVS) | COM | N69605108 | $9.3M | 593,403 | 0.6% |
| BioAge Labs Inc(BIOA) | COM | 09077V100 | $8.7M | 2,304,901 | 0.6% |
| Acadia Pharmaceuticals Inc(ACAD)Call | COM | 004225108 | $8.3M | 500,000 | 0.5% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $8.1M | 1,037,776 | 0.5% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $7.5M | 342,218 | 0.5% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $7.5M | 716,896 | 0.5% |
| Edgewise Therapeutics Inc(EWTX)Put | COM | 28036F105 | $7.0M | 320,400 | 0.5% |
| Immatics N.v(IMTX) | SHS | N44445109 | $7.0M | 1,554,304 | 0.5% |
| Praxis Precision Medicines I(PRAX) | COM | 74006W207 | $6.0M | 157,640 | 0.4% |
| Intuitive Surgical Inc(ISRG) | COM | 46120E602 | $5.9M | 11,984 | 0.4% |
| Uniqure NV(QURE) | SHS | N90064101 | $5.8M | 545,771 | 0.4% |